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There are two approaches to laparoscopic donor nephrectomy: standard laparoscopic donor nephrectomy (LDN) and hand-
assisted laparoscopic donor nephrectomy (HALDN). In this study we report the operative statistics and donor complications
associated with LDN and HALDN from large-center peer-reviewed publications. Methods. We conducted PubMed and Ovid
searches to identify LDN and HALDN outcome studies that were published after 2004. Results. There were 37 peer-reviewed
studies, each with more than 150 patients. Cumulatively, over 9000 patients were included in this study. LDN donors experienced
a higher rate of intraoperative complications than HALDN donors (5.2% versus. 2.0%, P<. 001). Investigators did not report a
signiﬁcant diﬀerence in the rate of major postoperative complications between the two groups (LDN 0.5% versus HALDN 0.7%,
P = .111). However, conversion to open procedures from vascular injury was reported more frequently in LDN procedures (0.8%
versus0.4%,P = .047).Conclusion.Atpresentthereisnoevidencetosupporttheuseofonelaparoscopicapproachinpreferenceto
the other. There are trends in the data suggesting that intraoperative injuries are more common in LDN while minor postoperative
complications are more common in HALDN.
1.Introduction
There has been a rapid increase in living organ donation
in order to bridge the shortfall between the demand and
supply of donor organs. Kidney transplant recipients have
beneﬁted considerably by the expansion in living donation.
The 2007 annual report from the Scientiﬁc Registry of
Transplant Recipients (SRTR) shows that 45% of all trans-
planted kidneys were obtained from living donors [1]. Until
1995, donor nephrectomy surgery was performed through
a large ﬂank incision. Subsequently, laparoscopic donor
nephrectomy (LDN) became the surgical approach of choice
[2].
EvidenceshowsthatLDNdoesnotadverselyaﬀectdonor
graft function or survival compared to kidney recovery
through an open approach [3]. Laparoscopic techniques
also reduce length of hospitalization, improve pain scores,
and produce a better cosmetic outcome [4–7]. Nonetheless,
LDN requires additional technical training with a distinct
learning curve, and surgeons may initially experience longer
operating and warm ischemic times [5, 8, 9]. Published
reports also suggest that LDN is more technically challenging
than open donor nephrectomy (ODN) in patients who are
greater than their ideal body weight [2].
SurgeonshavemodiﬁedthetechniqueofLDNinorderto
make the recovery of the donor kidney easier and safer. One
approach uses a longer incision at the extraction site so that
the surgeon’s hand can be inserted into the peritoneal cavity
to assist with laparoscopic donor nephrectomy [10, 11].
Some investigators report shorter warm ischemic times and
less intraoperative bleeding with hand-assisted laparoscopic
nephrectomy (HALDN) compared to LDN [12]. HALDN2 Journal of Transplantation
hasalsobeenusedindonorswhowerepreviouslyconsidered
poor candidates for LDN, including those who weigh more
than their ideal body weight, who have anatomic variations
in the renal vasculature or who had previous abdominal
surgery [12]. Generally the rate of complications appears
to be similar between HALN and LDN. However, the type
and severity of complications has not been systematically
compared.
Currently the choice of procedure largely depends on the
personal preference and experience of the surgeon [2, 13].
A 2008 survey of transplant fellowship training programs
reported that 41% of responding centers preferred LDN,
22% preferred HALDN, and 37% used a combination of
LDN and HALDN procedures [2]. The variability in practice
can be partly attributed to a lack of detail about the risks
associated with both techniques [12]. In this study we report
summarized information on the rate and type of donor
complications derived from large retro- and prospective
institutional publications on LDN and HALDN.
2. Methods
2.1. Literature Search. We performed Pubmed and Ovid
keywordsearchestoidentifyallstudiesonLDNandHALDN.
Search words included laparoscopic donor nephrectomy,
LDN, and HALDN. We included all literature that was
published between January 01, 2004 and April 30, 2009.
The inclusion criteria for our review were studies that
enlisted adult patients, only, described a transperitoneal
surgical technique, and were published in English. Studies
were included that described outcomes in greater than 150
LDN patients or 50 HALDN patients or studies that directly
compared outcomes between the two groups in any number
of patients. A total of 37 studies were included in the ﬁnal
analysis.Atotalof206studieswereexcludedbecausetheydid
not use standard laparoscopic or hand-assisted approaches
(e.g., retroperitoneal approach, robot-assistance, etc.), they
were review or editorial publications, or they did not contain
speciﬁc information on donor outcomes. In cases where
one study population was contained in more than one
publication, we analyzed the most recently published report
that included the largest study cohort and that focused on
donor outcomes.
2.2. Data Collection. We were unable to construct a standard
metadatabank for analysis because the design of all the
studies uncovered by the search was descriptive. Therefore
studies lacked standard techniques for validity assessment
and data abstraction such as blinding, reliability checks, or
duplicate observations. In addition, we accepted more than
one type of data collection method, including retrospective,
prospective, and randomized controlled. We therefore could
not use meta-analysis and chose instead to summate the data
inordertoprovideanestimateoftherisksandcomplications
associated with LDN compared to HALDN.
We summated the data for the categories of LDN and
for HALDN and recorded eight distinct patient and outcome
variables. These included age, body mass index (BMI), total
operative time, estimated blood loss, warm ischemic time,
length of hospital stay, intraoperative and postoperative
complications. Deaths during the admission hospitalization
were also recorded.
2.3. Data Analysis. Discrete variables were recorded as the
number of reported events, while continuous measures (age,
BMI, total donor operative time, estimated blood loss, warm
ischemia time, length of hospital stay) were expressed as
the weighted mean of the reported arithmetic means in the
dataset. Weighted mean calculations were based on sample
size due to the lack of reporting of the standard error from
many studies. In studies that did not explicitly deﬁne their
measure of total donor operative time we used a measure
from skin incision to skin closure. Twenty of the 34 studies
that reported total operative time did not give a speciﬁc def-
inition, and three studies were excluded from the calculation
of operative time because they used alternative endpoints in
their deﬁnition. Similarly, we estimated warm ischemia time
(WIT) from renal vessel occlusion to immersion in ice or
back-table perfusion if this information was not included.
Seventeen of 40 studies reporting WIT did not give an
explicit deﬁnition but did provide enough information to
estimate the WIT using the above deﬁnition.
We identiﬁed complications that represented signiﬁcant
donor morbidity or mortality and led to an escalation
in care. These were blood transfusion, aborted procedure,
conversion to open surgical procedure, rehospitalization,
reoperation, and death. Complication rates were compared
using a two-tailed z test of two binomial proportions. The
calculated weighted means were compared using the “glm”
procedure function in SAS software.
3. Results
3.1. Database. T h es e a r c hp r o d u c e d3 7s t u d i e st h a tm e t
all the inclusion criteria. Nine of the 37 studies reported
and compared outcomes of both HALDN and LDN. Twelve
described the outcomes of only HALDN outcomes and 16
described only LDN outcomes. There were 26 retrospective,
eight prospective, and one randomized control trial. Two
studies did not clearly deﬁne their study design. The dataset
derived from the 37 publications included 9296 patients, of
which 2562 were HALDN and 6734 were LDN. Details of
the study design are reported in Table 1. The intraoperative
and post-operative donor complications were classiﬁed into
categories based on the organ system that was injured
and if the injury was related to procedural problems. The
classiﬁcation of the intra and post-operative complications
is shown in Tables 2 and 3.
Patient demographics and intraoperative weighted mean
valuesaredisplayed inTable 1,althoughwecouldnotextract
complete information in all the analytic categories. Of the
37 studies, 34 reported total operative time, 22 reported
estimated blood loss, 30 reported WIT, and 29 reported
length of stay. In addition, the BMI of donor nephrectomy
patients was only reported in 18 studies, making it the least
reported variable.
The average age of LDN donors was 39.9 years while that
of the HALDN donors was 41.2 years. Donors had similarJournal of Transplantation 3
Table 1: Study characteristics, donor demographics and intraoperative data.
Author et al.
Total Warm
Study Cases Age BMI operative Operative ischemia Length of
type (years) (kg/m2) time blood loss time stay
(min) (mL) (min) (days)
L H LHLH L H L HL H LH
Anderson [14] R 103 34.4 25.9 283 2.3 3.7
Bargman [15] RCT 20 20 200 219 141.5 97.4 2.6 2.3 1.9 2.1
Branco [16] R 89 67 38.9 38 78.4 83 98.9 130.9 2.5 3.6 1.4 2.8
Breda [17] R 300 36.7 28.3 180 80 4.0
Chandak [18] P 144 44 198 160 2.9
Chin [9] R 500 40.3 27.3 208.2 197 3.5 2.3
Desai [19] 303 45.2 24.2 159.0 6.5 4.4
Diner [20] R 167 39.0 226.3 108.3 5.0 2.5
Dolce [21] P 217 39.6 177.3 71.1 1.1 3.6
Dols [22] P 283 50 222 206 5.6 3.5
El-Galley [23] P 80 43 184 50 4.0
Fettouh [24] R 400 32 117∗ 56 2.6
Fisher [25] R 200 42 27 229 243 2.6 1.9
Giron [26] R 85 34.3 132 125 4.0 2.5
Gupta [27] P 343 43 191 3.3 3.7
Hawasli [28] R 168 132 92 3.5 1.2
Heimbach [29] R 553 42 28.0 137∗ 2.3
Husted [30] R 213 40 41 41 27.5 192 186 3.3 3.9 1.9 1.9
Jacobs [31] R 738 40.2 27.7 202.1 128 2.8 2.7
Jeon [32] R 71 12 36 38 206.7∗ 143.4∗ 3.8 2.4
Keller [33] R 230 176 71 1.1 3.7
Ko [34] R 400 40.9 27.1 147.6 83.2 1.5 2.0
Kocak [35] R 482 318 39 41 27 29 1.6 1.2
Lai [36] P 12 12 48.6 44 22.5 25 215 258 4.5 3.8 5.8 5.6
Lallas [37] R 230 40.6 112 92.8 2.3
Li [38] R 65 157.92 37.38 3.3 5.0
Melcher [39] R 530 40.4 26.1 196 3.2
Minnee [40] P 158 46.7 173.8 3.2 4.9
Percegona [41] R 34 21 184 191 441 545 3.8 4.3 2.6 3.6
Permpongkosol [42] R 553 41.4
Rajab [43] R 80 38 26.5
Ruszat [44] R 12 33 46 50 24 24 212 192 307 208 4.0 2.1 13.0 11.0
Salazar [45] 11 24 39 44 26 26 213 235 3.0 4.0
Seo [46] R 100 38.1 23 202 3.0 4.1
Simforoosh [47] P 241 27.8 24.8 136.5 7.5
Su [48] R 381 253 334 4.9 3.3
Sundaram [49] R 253 39.3 26.1 199 115 2.2 2.8
Total 6734 2562
Weighted mean 39.9 41.2 26.8 27.3 187.0 189.3 144.0 128.6 3.7 2.5 2.7 3.0
Diﬀerence (L–H) (95% CI) −1.3(−4.2, 1.7) −0.5(−1.8, 0.8) −2.3(−31.4, 26.7) 15.4(−65.1, 95.8) 1.2(0.1, 2.3) −0.3(−1.1, 0.6)
P-value .401 .426 .876 .711 .037† .547
R:Retrospective; P:Prospective; RCT:Randomized Control Trial; L:LDN; H:HALDN.
∗Excluded from weighted mean calculation (alternative endpoints); †P< .05.4 Journal of Transplantation
Table 2: Intraoperative complications of LDN and HALDN
LDN HALDN P-value
Bowel injury 27 0.4% 3 0.1% .031†
Liver/mesenteric/splenic injury 48 0.7% 4 0.2% .001†
Pulmonary injury
Atelectasis 2 <0.0% 0 0.0% .383
Diaphragm injury 4 0.1% 0 0.0% .217
Pneumothorax 10 0.1% 0 0.0% .051
16 0.2% 0 0.0% .014†
Renal/ureteral injury
Bladder injury 5 0.1% 1 <0.0% .550
Degloving of the kidney capsule 2 <0.0% 2 0.1% .315
Renal laceration 9 0.1% 0 0.0% .064
Ureteral injury 10 0.1% 2 0.1% .398
26 0.4% 5 0.2% .154
Vascular injury/bleeding
Bleeding-vascular injury 97 1.4% 24 0.9% .056
Major bleeding (> 2U P R B C so r> 500 mL) 35 0.5% 3 0.1% .007†
132 2.0% 27 1.1% .003†
Procedural complications
Conversion—Elective/obesity 17 0.3% 4 0.2% .382
Conversion—reason not reported/other 19 0.3% 5 0.2% .460
Diﬃcult manual extractions/entrapment sack malfunction 12 0.2% 0 0.0% .033†
Endotracheal intubation/extubation diﬃculties 3 <0.0% 0 0.0% .285
Staple misﬁre 4 0.1% 0 0.0% .217
55 0.8% 9 0.4% .015†
Other complications
Cardiac arrhythmias 2 <0.0% 0 0.0% .383
Hydrocele 2 <0.0% 0 0.0% .383
Transient CO2 pneumoperitoneum 2 <0.0% 0 0.0% .383
Other 40 0.6% 2 0.1% .001†
46 0.7% 2 0.1% <.001†
Total intraoperative complications 350 5.2% 50 2.0% <.001†
†P< .05
average BMI (26.8kg/m2 LDN versus 27.3kg/m2 HALDN).
Mean operative time was 187.0 minutes in LDN procedures
and 189.3 minutes in HALDN procedures. Mean length of
stay was slightly shorter but not signiﬁcantly diﬀerent for
LDN donors (2.7 days versus 3.0 days). Conversely, HALDN
donor warm ischemic time was shorter (3.7 minutes versus
2.5 minutes) and estimated blood loss was less (144.0mL
versus 128.6mL). However, only WIT was found to be
signiﬁcantly diﬀerent between LDN and HALDN cases (P =
.037).
3.2. Intraoperative Complications. The rate of intraoperative
complications was signiﬁcantly higher in LDN donors
compared to HALDN donors (5.2% versus 2.0%, P<. 001).
Vascular injury or bleeding, bowel injury, pulmonary injury,
andliver,mesentericorsplenicinjuryweresigniﬁcantlymore
commonwithLDN(Table 2).Therewasalsoagreaterrateof
technical diﬃculties encountered during surgery with LDN.
We did not ﬁnd a signiﬁcant diﬀerence in the incidence of
renal or ureteral injury.
The LDN rate of vascular injury or bleeding was 2.0%
while the HALDN rate was only 1.1% (P = .003). Within the
LDN group there was also a higher rate of major bleeding
(deﬁned as greater than two units of packed red blood cells
or 500mL blood loss). The rate of bleeding due to other
vascularinjurieswasalsoelevatedinLDNdonors,butwedid
not ﬁnd a statistically signiﬁcant diﬀerence when compared
with HALDN (1.4% versus 0.9%, P = .056). LDN donorsJournal of Transplantation 5
also experienced signiﬁcantly higher rates of bowel injury
(0.4%versus0.1%,P = .031),andliver,mesentericorsplenic
injury (0.7% versus 0.2%, P = .001).
Procedural complications occurred more frequently
in LDN than in HALDN cases (0.8% versus 0.4%,
P = .008). Most complications were reported as diﬃcult
manual extractions, entrapment sack malfunctions, or elec-
tive conversions to open procedures. Only diﬃcult manual
extractions and entrapment sack malfunctions were found
to be signiﬁcantly elevated (0.2% versus 0.0%, P = .033).
3.3. Postoperative Complications. The incidence of post-
operative complications in LDN donors was statistically
lower than in HALDN donors (6.7% versus 8.6%, P =
.002) (Table 3). There was no statistical diﬀerence found
between the summated rates of cardiac, neural, pulmonary,
or vascular complications. However, we observed striking
diﬀerences between LDN and HALDN rates of incisional,
renal, and ureteric complications. Incision and wound
complications occurredin 1.7% of LDNdonors comparedto
3.1% of HALDN donors (P<. 001). Notably, LDN had lower
rates of incisional hernias (0.1% versus 0.7%, P<. 001) and
wound infections (1.4% versus 2.0%, P = .034). The rates
of abdominal and bowel complications were also found to be
signiﬁcantly diﬀerent. There were no statistical diﬀerences in
other complications listed in this category.
LDN donors had a markedly lower incidence of renal
and ureteric complications (0.4% versus 1.6%, P<. 001).
This ﬁnding was explained by the larger number of HALDN
patients who suﬀered from urinary retention and urinary
tract infections (both 0.2% LDN versus 0.7% HALDN,
P<. 001). The rate of post-operative ileus was signiﬁcantly
greater in HALDN donors than in LDN donors (0.5% versus
1.0%, P = .008). This elevated ileus rate was the primary
determinant of overall bowel complications in HALDN
groups (0.7% versus 1.1%, P = .025).
The LDN and HALDN donors experienced similar rates
of post-operative vascular complications and hematomas,
0.9% versus 0.7%, respectively (P = .525). However,
there were signiﬁcant diﬀerences within this category. The
rates of subcapsular hematoma and continued bleeding
were statistically greater in the LDN donors (P = .026).
Conversely, only HALDN donors experienced pulmonary
embolism or deep vein thrombus (0.0% versus 0.2%, P =
.001).
3.4. Major Complications. T h es u m m a t e dr a t eo fm a j o r
intraoperativecomplicationswassigniﬁcantlyhigherinLDN
donors than in HALDN donors (2.2% versus 1.1%, P =
.001). This diﬀerence was due to major injuries that required
blood transfusions or conversion to an open procedure.
Blood transfusions were needed in 0.8% of LDN donors
versus only 0.2% of HALDN donors (P = .004). The overall
rate of conversions to open surgery was also signiﬁcantly
higher in LDN patients (1.3% versus 0.8%, P = .030),
primarily due to bleeding (0.8% versus 0.4%, P = .047).
We did not ﬁnd a signiﬁcant diﬀerence in the rate of
conversions to an open procedure due to obesity or other
reasons. Even though there were two aborted procedures
in the LDN group, due to a colon and a mesenteric vein
injury,nosigniﬁcantdiﬀerencewasdetectedbetweenthetwo
groups.
The rate of major post-operative complications was
similarinHALDNdonors(0.5%versus0.7%,P = .111).Sig-
niﬁcant diﬀerences were only observed in a higher incidence
of rehospitalization among HALDN donors (0.3%) versus
LDN donors (0.1%) (P = .007). Ileus was the most common
reported reason for rehospitalization. Reoperations were
needed in 0.4% of both typesof laparoscopic procedure(P =
.807). The indications for additional surgery included bleed-
ing or hematoma, bowel injury, small bowel obstruction,
andincisionalhernias.Twopatientsdiedperioperatively:one
HALDN donor died due to a thromboembolism and one
LDN donor died due to a myocardial infarction.
The overall rate of major intraoperative and post-
operative complications was 2.6% in LDN donors and was
1.8% in HALDN donors. The diﬀerence was found to be
statistically signiﬁcant (P = .013). The relative rates of all
major complications are found in Table 4.
4. Discussion
Living donor nephrectomy is unique in that the donor
assumes an operative risk yet has no underlying disease
and does not have any direct medical beneﬁt from the
procedure. This explains the clear imperative to ensure
that donor complications are minimized [3, 40]. While
LDN and HALDN techniques have been shown to be
safe compared to open surgery, both techniques appear to
have diﬀerent rates and types of complications. The data
we analyzed suggest that LDN donors experience higher
rates of intraoperative complications than HALDN donors.
Furthermore, the incidence of major bleeding and overall
vascular injury was also greater in the LDN group and more
commonlyrequiredopenconversionandbloodtransfusions.
Conversely, the rate of postoperative wound infections renal
and ureteric injuries appeared to be greater in the HALDN
group.
WhileproponentsofHALDNpointouttheadvantagesof
a kidney extraction site and improved tactile control during
the procedure, investigators have questioned if HALDN
patients suﬀer from a greater number of post-operative
complications [50]. Our data analysis strongly supports
the impression that HALDN donors have greater incision
morbiditythanLDNdonors.Thiscontrastswiththeﬁndings
of Kocak et al., who reported no signiﬁcant diﬀerences
in incision morbidity in a large direct comparison of
LDN and HALDN donor complications [35]. We have no
data to explain this discrepancy, but it may suggest that
institutional practices and technical experiences play a role
in determining outcomes unique to each study. We did not
ﬁnd signiﬁcant diﬀerences in the rate of re-hospitalization
due to infection nor the rate of re-operation for incisional
hernia.
Post-operative bowel complications were cited as signif-
icant sources of donor morbidity in HALDN and thus are
the reason why some centers choose to employ the LDN
technique in favor of HALDN [35]. We identiﬁed greater6 Journal of Transplantation
Table 3: Postoperative complications of LDN and HALDN.
LDN HALDN P-value
Abdominal complications
Chylous ascites 5 0.1% 4 0.2% .257
O t h e r 1 00 . 1 %1 10 . 4 % .011†
15 0.2% 15 0.6% .006†
Bowel complications
I l e u s 3 50 . 5 %2 61 . 0 % .008†
Intestinal obstruction 9 0.1% 2 0.1% .486
Other 1 <0.1% 1 <0.1% .478
45 0.7% 29 1.1% .025†
Cardiac complications
Hypertension requiring medication 11 0.2% 0 0.0% .041†
Myocardial infarction 1 <0.0% 0 0.0% .537
Other 2 <0.1% 1 <0.1% .823
14 0.2% 1 <0.0% .070
Incision/wound complications
Incisional hernia 10 0.1% 18 0.7% <.001†
Incisional, back or abdominal pain 12 0.2% 9 0.4% .116
Wound infection 91 1.4% 50 2.0% .034†
Other 3 <0.1% 3 0.1% .218
116 1.7% 80 3.1% <.001†
Neural complications
Extremity neuropathy 13 0.2% 3 0.1% .430
Paralysis, emesis, vomitus 4 0.1% 2 0.1% .752
17 0.3% 5 0.2% .611
Pulmonary complications
Pneumonia 13 0.2% 4 0.2% .710
Other 7 0.1% 1 <0.1% .340
20 0.3% 5 0.2% .397
Renal/ureteric complications
Urinary retention 12 0.2% 19 0.7% <.001†
Urinary tract infection 12 0.2% 19 0.7% <.001†
Other 5 0.1% 2 0.1% .952
29 0.4% 40 1.6% <.001†
Vascular/hematoma complications
Continued bleeding 13 0.2% 0 0.0% .026†
Hematoma 28 0.4% 8 0.3% .473
Pulmonary embolism/DVT 0 0.0% 5 0.2% <.001†
Subcapsular hematoma 13 0.2% 0 0.0% .026†
Other 5 0.1% 6 0.2% .045†
59 0.9% 19 0.7% .525
Other complications 135 2.0% 26 1.0% .001†
Total postoperative complications 450 6.7% 220 8.6% .002†
†P< .05
ratesofileusinHALDNdonorsandre-hospitalizationdueto
ileus. Unexpectedly, post-operative renal and ureteric com-
plications were also signiﬁcantly elevated among HALDN
donors. This may be a concern and may motivate surgeons
to select the LDN in preference to the HALDN technique.
However, we found that 50% of observations came from one
HALDN trial [25] and 25% came from another [29]. There-
fore the increased rate of ureteric and renal complications
could be due to unidentiﬁed center speciﬁc practices that are
not found at other institutions.Journal of Transplantation 7
Table 4: Major intraoperative and postoperative complications of LDN and HALDN.
LDN HALDN P-value
Intraoperative complications
Aborted procedures
Colon injury 1 <0.1% 0 0.0% .537
Mesenteric vein injury 1 <0.1% 0 0.0% .537
2 0.0% 0 0.0% .383
Blood transfusions 51 0.8% 6 0.2% .004†
Conversions
Bleeding 55 0.8% 11 0.4% .047†
Elective/obesity 15 0.2% 4 0.2% 0.525
Reason not reported/other 19 0.3% 5 0.2% 0.460
89 1.3% 20 0.8% .030†
Other
Bowel resection 1 <0.1% 0 0.0% 0.537
Splenectomy 4 0.1% 2 0.1% 0.752
5 0.1% 2 0.1% 0.952
Total intraoperative complications 147 2.2% 28 1.1% .001†
Post-operative complications
Re-hospitalizations
Ileus 3 <0.1% 5 0.2% .027†
Infection 1 <0.1% 1 <0.1% .478
Pain 0 0.0% 1 0.0% .105
4 0.1% 7 0.3% .007†
Re-operations
Bleeding/hematoma 10 0.1% 1 <0.1% .170
Bowel injury 2 <0.1% 1 <0.1% .823
Incisional hernia 4 0.1% 0 0.0% .217
Small bowel obstruction 6 0.1% 3 0.1% .698
Other 4 0.1% 4 0.2% .155
26 0.4% 9 0.4% .807
Death
Myocardial infarction 1 <0.1% 0 0.0% .537
Pulmonary embolism 0 0.0% 1 <0.1% .105
1 0.0% 1 0.0% .478
Total post-operative complications 31 0.5% 17 0.7% .222
Total major complications 178 2.6% 45 1.8% .013†
†P< .058 Journal of Transplantation
T h e r ei sd e b a t ei nt h el i t e r a t u r ei fo n el a p a r o s c o p i ct e c h -
nique is preferential to the other in obese donors. Heimbach
et al. found that HALDN was safe in obese donors (BMI>30
kg/m2); however total operative times and intraoperative
complications were increased in signiﬁcantly obese donors
[29]. In contrast, Sundaram et al. did not ﬁnd signiﬁcantly
elevated operative or post-operative complication rates in
obese LDN donors [49]. In our limited analysis, we found
that obese LDN and HALDN donors had nearly equivalent
BMIs of 26.8kg/m2 and 27.3kg/m2, respectively. We did not
identify diﬀerential conversion rates secondary to obesity;
however, there is insuﬃcient data to draw ﬁrm conclusions
on this topic.
Total operative time, warm ischemia time, and length
of stay are surrogate measures of outcome. Warm ischemia
time was the only operative parameter that was signiﬁcantly
diﬀerentbetweentheLDNandHALDNgroups,withshorter
WIT reported in HALDN procedures. Investigators have
attributed this diﬀerence to the increased tactile control in
HALDN, leading to faster vessel management and kidney
extraction [3, 6, 7, 13, 40]. We did not ﬁnd any statistical
diﬀerence for either total operative time or length of hospital
stay between the techniques. The studies that directly
compared the latter two variables in LDN and HALDN
procedures reported conﬂicting trends. It was diﬃcult to
compare total operative time with conﬁdence because inves-
tigators do not always report a uniform end point that would
allow a direct a comparison between institutions. Despite
this limitation we observed a wide range in total operative
times for each technique (LDN 78.4–253 minutes; HALDN
83–283 minutes). This suggests that center-speciﬁc practices
and/or experiences inﬂuence the operative time reported in
the literature.
Our data summarizes the rates of complications and
operative statistics reported in the peer-reviewed literature
of large institutional studies. Therefore, there are limitations
to our study. We have no resources to test the validity of
the published ﬁndings or identify all the center speciﬁc
variables that determined the reported outcome. We there-
fore cannot guarantee that the observations calculated from
the summated data can be generalized to other transplant
centers. Our conclusions are therefore limited to the speciﬁc
dataset that was analyzed. While the datasets include a
large number of patients, there could be a systematic
bias associated with restricting our search to published
studies. The use of publications with diverse study designs
preventedusfromusingmeta-analysis.Thus,weusedsimple
observational outcomes from the published peer-reviewed
literature to create a dataset for analysis and did not use
a common measure of eﬀe c ts i z e .B e c a u s ew ew e r eu n a b l e
to control the eﬀects of all study characteristics, the dataset
incorporates several sets of assumptions and conditions.
Even though the data set must be interpreted with caution,
it provides a large compendium of outcome information as
a ﬁrst step in assessing performance for quality outcome
purposes
At present there is no evidence that proves one laparo-
scopic technique is superior to the other. There are however
consistent trends in the data suggesting that intraoperative
injuries are more common in LDN patients while post-
operative injuries are more common in HALDN donors.
Analysis of major donor morbidity diﬀerentiates the two
techniques. Transfusions and conversion to open procedures
from vascular injury are the most common sources of major
donor morbidity reported in the literature. These are cited
more frequently in LDN procedures. Conversely, there did
notappeart obeadiﬀerenceintheoverallrateofmajorpost-
operative complications. As such, this paper suggests that the
HALDN approach has less associated risk of major donor
morbidity.
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